Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Total Current Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Current Liabilities ₹14,682 Cr₹12,199 Cr₹11,494 Cr₹8,156 Cr₹10,665 Cr

What is the latest Total Current Liabilities ratio of AUROBINDO PHARMA ?

The latest Total Current Liabilities ratio of AUROBINDO PHARMA is ₹14,682 Cr based on Mar2025 Consolidated results.
Year Total Current Liabilities
Mar2025₹14,682 Cr
Mar2024₹12,199 Cr
Mar2023₹11,494 Cr
Mar2022₹8,156 Cr
Mar2021₹10,665 Cr

How is Total Current Liabilities of AUROBINDO PHARMA Trending?

Years Total Current Liabilities % Change
Mar2025 ₹14,682 Cr
20.36
Mar2024 ₹12,199 Cr
6.14
Mar2023 ₹11,494 Cr
40.92
Mar2022 ₹8,156 Cr
-23.53
Mar2021 ₹10,665 Cr -

Compare Total Current Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹68,548.9 Cr -5.5% -2.2% -6.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,019.0 Cr -3% -3.6% -4.9% Stock Analytics
DIVIS LABORATORIES ₹168,752.0 Cr -3.1% 0.1% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,542.0 Cr -3.7% 4% 18.8% Stock Analytics
CIPLA ₹115,883.0 Cr -1.3% -4.6% -1.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,024.7 Cr -4.2% -7% -11.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-5.5%

-2.2%

-6.1%

SENSEX

-1.9%

-2.2%

7.4%


You may also like the below Video Courses